BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191017
DTSTAMP:20190914T001844Z
CREATED:20190722T154929Z
LAST-MODIFIED:20190914T001844Z
UID:29649-1571097600-1571270399@globalbiodefense.com
SUMMARY:BARDA Industry Day 2019
DESCRIPTION:The Biomedical Advanced Research and Development Authority (BARDA) annual Industry Day 2019 conference on U.S. government medical countermeasures is planned for 15-16 October 2019 in Washington\, D.C. \nA component of the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR)\, BARDA will brief on program priorities and network with public and private sector colleagues on developing medical countermeasure or platform technology to combat chemical\, biological\, radiological\, or nuclear (CBRN) threats\, pandemic influenza or other emerging infectious diseases. \nThe Industry Day event will be held at Grand Hyatt and Washington Marriott at Metro Center in Washington\, DC. \nBARDA Industry Day brings together over >1\,000 participants to exchange information about the government’s public health needs\, and industry’s technologies\, capabilities\, and products that can fill those requirements. \nLightning Talks to showcase innovative discoveries and promote networking growth at the conference will be featured on the morning of October 16th. \nLightning Talks are intentionally designed to be brief\, energetic\, and full of information to pique the curiosity of industry and government colleagues and prospective partners. If you are interested in submitting a topic to present on behalf of yourself or your company\, please enter your information as requested and provide a brief (maximum 500 word) summary of your proposed presentation\, with optional 1 slide. \nLightning Talk applications must be received by 11:59 PM ET September 13\, 2019. BARDA will notify those that have been accepted for Lightning Talks the week of September 22\, 2019. Learn more here. \nPlease visit MedicalCountermeasures.gov or http://bit.ly/BARDA2019 for official updates in the BID 2019 event.
URL:https://globalbiodefense.com/event/barda-industry-day-2019/
LOCATION:Washington DC Area\, Washington\, DC\, United States
CATEGORIES:Conference,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/07/barda-industry-day-aspr-register.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190517
DTEND;VALUE=DATE:20190518
DTSTAMP:20190513T160228Z
CREATED:20190504T154020Z
LAST-MODIFIED:20190513T160228Z
UID:27240-1558051200-1558137599@globalbiodefense.com
SUMMARY:DARPA ReVector Proposers Day
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day meeting on 17 May 2019 to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. \nThe goal of ReVector is to develop an easily delivered treatment — for example\, a topical solution — that safely and temporarily modifies the human skin microbiome to alter scents and thereby reduce attraction of disease-spreading mosquitoes. \nThe Proposers Day will include overview presentations by DARPA personnel and potential government partners; an information session during which government personnel will respond to questions posed by participants; “lightning” talks (three minutes\, one slide) to allow potential proposers to highlight technical capabilities of interest and promote teaming; and short sidebars with DARPA personnel for discussion of any proprietary information that participants would not want to disclose in the other open sessions. \nAttendance at this event is not a requirement for submission of a proposal or selection for funding. Information relayed during the Proposers Day will be made available on the BTO section of the DARPA Opportunities page: http://www.darpa.mil/work-with-us/opportunities. \nDue to space limitations\, attendance is limited to no more than three attendees per division/department unless capacity is not reached. \nParticipants must register in advance through the registration website. You will be required to show government-issued\, picture identification that is compliant with the REAL ID Act of 2005. \nInformation about registration and various other meeting details can be found at the registration website. \nFurther administrative questions should be addressed to DARPA-SN-19-48@darpa.mil. Please refer to the ReVector Proposers Day (DARPA-SN-19-48) in all correspondence. \nDARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore\, the ReVector Proposers Day is open only to registered potential applicants\, and not to the media or general public.
URL:https://globalbiodefense.com/event/darpa-revector-proposers-day/
LOCATION:Executive Conference Center (ECC)\, 4075 Wilson Boulevard\, Arlington\, VA\, 22203\, United States
CATEGORIES:Conference,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/05/darpa-bto-revector-proposers-day.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181214
DTEND;VALUE=DATE:20181215
DTSTAMP:20181224T223152Z
CREATED:20181201T173734Z
LAST-MODIFIED:20181224T223152Z
UID:19521-1544745600-1544831999@globalbiodefense.com
SUMMARY:DARPA Panacea Program - Accessing the Dark Proteome
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day to provide information on the structure and objectives of the Panacea program. \nThe event will be held on December 14\, 2018 from 10:00 AM to 2:00 PM EST at the Executive Conference Center (ECC; 4075 Wilson Blvd.\, Suite 300\, Arlington\, VA 22203). Advance registration is required. \nPanacea aims to integrate systems pharmacology and advanced medicinal chemistry approaches to expand the human drug target space for therapeutic interventions in the areas of acute management of pain and inflammation and the improvement of physiological endurance under oxygen-limited conditions or environments. Panacea will support the development and proof-of-concept demonstration of a new integrated platform for the rapid prediction\, synthesis\, and validation of pharmacological interventions. \nNew drug development for the Panacea program will be focused towards solving two critical problems facing DoD personnel: alleviating pain/inflammation without unwanted side effects and positively mitigating metabolic stress. \nDARPA seeks to bridge the gaps between the chemical space required to identify and produce novel pharmacological interventions and the complex biological space whose functions must be quantified in order to predict and validate the benefits of those interventions for these two desired indications. \nThe success of the Panacea program will represent a paradigm shift in the new drug discovery process and provide new technology that enables more rapid\, safe and effective therapeutic drug development for military and civilian health. \nSpecifically excluded from this effort is research that primarily results in evolutionary improvements to the existing state of practice\, that requires genetic manipulation of the intended recipient\, or that relies on discovering novel pharmacodynamic space for known therapeutics to identify additional indications. \nAdditional details\, including registration instructions\, are available at https://go.usa.gov/xP6hD. Please address administrative questions to DARPA-SN-19-12@darpa.mil\, and refer to the Panacea Proposers Day (DARPA-SN-19-12) in all correspondence.
URL:https://globalbiodefense.com/event/darpa-panacea-program-accessing-the-dark-proteome/
LOCATION:Strategic Analysis Executive Conference Center\, 4075 Wilson Blvd.\, Suite 300\, Arlington\, VA\, 22203\, United States
CATEGORIES:Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/12/darpa-panacea-baa.jpg
END:VEVENT
END:VCALENDAR